Avantor Investor Conference Presentation Deck

Track record of performance ORGANIC REV. GROWTH LT TARGET: 4-6% -6.5% Organic CAGR (2019-2022E) Reported revenue $6.0B 2019 ~$7.5B 2022E Navantor™ ADJ. EBITDA MARGIN LT TARGET: 50 - 100 bps ~130 Average bps/ year expansion (2019-2022E) 17.1% 2019 ~20.9% 2022E ADJUSTED NET INCOME LT TARGET: Mid-teens+ ~37% CAGR (2019-2022E) $374M 2019 Note: 2022E data based on full year guidance as of Q3 earnings call (midpoint where relevant). ~$950M 2022E ABOVE LONG-TERM PLAN ACROSS ALL METRICS FREE CASH FLOW -2.5x Growth (2019-2022E) $302M 2019 ~$800M 2022E 41st Annual J.P. Morgan Healthcare Conference 8

View entire presentation